2 1 Shi Ji Jing Ji Bao Dao·2025-09-22 02:12Core Insights - The report highlights significant target price increases for several companies from September 15 to September 21, with Guizhou Moutai, Hanwang Technology, and Chunli Medical leading the way with target price increases of 77.12%, 72.37%, and 64.90% respectively, indicating strong bullish sentiment in the liquor, software development, and medical device sectors [1][2]. Target Price Increases - Guizhou Moutai (600519) received a target price of 2600.00 CNY, reflecting a 77.12% increase [2]. - Hanwang Technology (002362) has a target price of 42.23 CNY, with a 72.37% increase [2]. - Chunli Medical (688236) has a target price of 37.73 CNY, showing a 64.90% increase [2]. - Other notable companies include Ruip Bio (300119) with a 64.74% increase and Xindian Software (688232) with a 62.82% increase [2]. Broker Recommendations - A total of 510 companies received broker recommendations during the same period, with Huajin Technology and Hengxuan Technology each receiving 4 recommendations, and Chuangjiang New Material receiving 3 [3][4]. - Huajin Technology (603296) had a closing price of 97.93 CNY and was recommended by 4 brokers [4]. Rating Adjustments - Brokers raised ratings for 15 companies, including Bertley (10356) from "Hold" to "Buy" and Placo New Materials (300811) from "Hold" to "Buy" [5][6]. - Conversely, 15 companies had their ratings lowered, such as Jianshi Yuan (603369) from "Buy" to "Hold" [6]. First-Time Coverage - During the same period, 92 instances of first-time coverage were reported, with notable mentions including Rhein Biotech receiving a "Buy" rating from CITIC Securities and Xiamen Port receiving a "Recommended" rating from Huachuang Securities [7].